Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at The James

NCT01643954 | Active Not Recruiting

• 1 other identifier: OSU-08108
• Study Type: interventional
• Target: 1,531
• Locations: 1 country
• Sites: 1

Brief Summary

This is a retrospective/prospective Analysis of surgical outcomes of robotic prostatectomy.

Conditions

Prostate Cancer

Keywords

prostatectomy; surgery; prostate cancer

Outcome Measures

Primary Outcomes (1)

• Collect and analyze descriptive characteristics of patient population and summarize patient outcome data.

  up to 20 years

Secondary Outcomes (4)

• Correlate the patient characteristics to the surgical outcomes.

  up to 20 years

• Determine the overall survival

  up to 20 years

• Determine the rate of local recurrence in patients undergoing robotic prostatectomy and compare these metrics to historical controls.

  up to 20 years

• disease- free survival

  up to 20 years

Study Arms (2)

Arm A

NO INTERVENTION

Patients with prostate cancer who have undergone robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University Medical Center.

Arm B

OTHER

Patients with prostate cancer that will undergo robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University Medical Center .

Procedure: robotic radical prostatectomy

Interventions

robotic radical prostatectomy PROCEDURE

robotic assisted surgery

Also known as: laparoscopic surgery, The da Vinci system

Arm B

Eligibility Criteria

• Age: 18 Years+
• Sex: male
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients with prostate cancer who have undergone robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University Medical Center.
• Ability to understand and willingness to sign the written informed consent document.
• years and older
• ARM B:
• Patients with prostate cancer that will undergo robotic radical prostatectomy at The Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University Medical Center.
• Ability to understand and willingness to sign the written informed consent document.
• years and older

Sponsors & Collaborators

• Ohio State University Comprehensive Cancer Center: lead

Study Sites (1)

Ohio State University Medical Center

Columbus, Ohio, 43210, United States

Location

Related Links

• Jamesline

MeSH Terms

Conditions

Prostatic Neoplasms

Interventions

Laparoscopy

Condition Hierarchy (Ancestors)

Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Genital Diseases, Male; Genital Diseases; Urogenital Diseases; Prostatic Diseases; Male Urogenital Diseases

Intervention Hierarchy (Ancestors)

Endoscopy; Diagnostic Techniques, Surgical; Diagnostic Techniques and Procedures; Diagnosis; Minimally Invasive Surgical Procedures; Surgical Procedures, Operative

Study Officials

• Steven Clinton, MD

  Ohio State University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: May 8, 2012
• First Posted: July 18, 2012
• Study Start: September 23, 2008
• Primary Completion (Estimated): July 31, 2027
• Study Completion (Estimated): July 31, 2027
• Last Updated: December 31, 2025

Record last verified: 2025-12

Locations

US (1)